Form 4: Doximity Director Exercises Options and Sells Shares Under Pre-Arranged Trading Plan

A Doximity, Inc. director exercised stock options and subsequently sold 10,000 shares of Class A Common Stock for $60 per share, as part of a pre-established Rule 10b5-1 trading plan.

Summary

• Regina M. Benjamin, a Director of Doximity, Inc. (DOCS), engaged in a series of transactions on June 25, 2025.
• She exercised stock options to acquire 10,000 shares of Class B Common Stock at an exercise price of $2.21 per share.
• These 10,000 Class B shares were immediately converted into 10,000 shares of Class A Common Stock.
• Subsequently, 10,000 shares of Class A Common Stock were sold at a price of $60 per share.
• The sale was executed automatically under a Rule 10b5-1 trading plan established on February 26, 2025.
• Following these transactions, Ms. Benjamin beneficially owns 16,618 shares of Class A Common Stock and 371,138 shares of Class B Common Stock.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing reporting a pre-planned insider transaction. It does not contain positive or negative news about the company's operations or financial performance.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-planned transaction rather than a reaction to new negative information.
• The exercise of options suggests the director is realizing value from previously granted equity.

Negatives

• An insider sale, even if pre-planned, reduces the director's direct equity stake in Class A Common Stock.

Future Outlook

The document does not provide specific forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports an insider transaction.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information to assess broader industry trends or competitive positioning for Doximity, Inc. It reflects an individual director's equity management strategy.

Comparison to Industry Standards

• This document is a standard insider transaction report (Form 4) and does not contain information that allows for a direct comparison of Doximity's operational or financial results against industry benchmarks or specific comparable companies/projects. The transaction itself is a common occurrence for executives managing their equity compensation.

Stakeholder Impact

• Shareholders: The sale by a director could be perceived as a slight reduction in insider confidence, though mitigated by the pre-planned nature of the transaction. It also represents a director realizing value from their equity compensation.

Key Dates

Keywords

Doximity, DOCS, SEC Form 4, Insider Trading, Stock Option Exercise, Share Sale, Rule 10b5-1 Plan, Director Transaction, Class A Common Stock, Class B Common Stock